Nutrigene Biosciences Private Limited, a active private limited company, was established on 20 October 2020 in Hyderabad, Telangana, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24290TG2020PTC145055. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.66 Cr.
Formerly known as Ikigai Bioworks Private Limited, Afya Nutrition And Biosciences Private Limited. It upholds a compliant status. Its leadership includes Trushit Pramodray Mehta (Director), Tejash Vijay Shah (Director), Keerthi Vardhan Vadlamani (Ceo). Past directors included Trushit Pramodray Mehta, Savitri Vadlamani, Tejash Vijay Shah. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No 201, Teja Block My Home Navadeepa , Madhapur, Hyderabad, Telangana, 500081.
U24290TG2020PTC145055
145055
20 October 2020
₹5.00 Cr
₹4.66 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Nutrigene Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Trushit Pramodray Mehta | Director | 21 Aug 2023 | Current |
| Tejash Vijay Shah | Director | 21 Aug 2023 | Current |
| Keerthi Vardhan Vadlamani | Ceo | 01 Oct 2023 | Current |
| Raheel Dharmesh Shah | Director | 21 Aug 2023 | Current |
| Katta Vijay Kumar | Director | 21 Aug 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 08 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 08 Sep 2023 | Past |
| Pramod Abcsdd | Director | 30 Sep 2023 | Past |
| Pramod Abcsdd | Director | 30 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nutrigene Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22016.85% increase. The company also saw a substantial fall in profitability, with a 424.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nutrigene Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Nutrigene Biosciences has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nutrigene Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutrigene Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nutrigene Biosciences Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
Keerthi Vardhan Vadlamani was appointed as a Ceo was appointed as a Ceo on 03 Sep 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
The activity Nutrigene Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Keerthi Vardhan Vadlamani was appointed as a CEO was appointed as a CEO on 01 Oct 2023 & has been associated with this company since 2 years 2 months . was documented.
Progress on Trushit Pramodray Mehta was appointed as a Director was appointed as a Director on 21 Aug 2023 & has been associated with this company since 2 years 3 months . was documented.
Tejash Vijay Shah was appointed as a Director was appointed as a Director on 21 Aug 2023 & has been associated with this company since 2 years 3 months . was recorded as a recent event.
The CIN of Nutrigene Biosciences Private Limited is U24290TG2020PTC145055.
Nutrigene Biosciences Private Limited is headquartered at Flat No 201, Teja Block My Home Navadeepa , Madhapur, Hyderabad, Telangana, 500081.
Nutrigene Biosciences Private Limited was incorporated on 20 October 2020.
The current directors of Nutrigene Biosciences Private Limited are
The primary industry of Nutrigene Biosciences Private Limited is Manufacturing.
Nutrigene Biosciences Private Limited is unlisted.
The authorized capital of Nutrigene Biosciences Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.66 Cr.
The compliance status of Nutrigene Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX